Gassel H J, Otto C, Klein I, Meyer D, Timmermann W, Steger U, Gasser M, Ulrichs K, Thiede A
Department of Surgery, University of Wuerzburg, Germany.
Transpl Int. 2000;13 Suppl 1:S465-70. doi: 10.1007/s001470050384.
Long-term graft acceptance and tolerance induction after allogeneic rat liver transplantation are well described. However, the underlying mechanisms remain unclear. In this study we investigated the cellular events within the liver graft during initial immunosuppression and long-term acceptance. Orthotopic liver transplantation was performed in the Dark Agouti (DA)-to-Lewis (LEW) and LEW-to-DA rat strain combination. In order to achieve long-term acceptance, LEW recipients of DA livers were treated with two different short-term therapies. Non-parenchymal cells (NPC) were isolated from liver allografts on days + 10 and + 100 after transplantation and donor-specific leukocytes were immunophenotyped by flow cytometry. Both the monotherapy and triple therapy prolonged graft survival (> 100 days). Liver allografts from LEW donors into DA recipients were spontaneously accepted across a complete MHC mismatch without immunosuppression. Liver allograft rejection was induced by infiltrating alloreactive immunocompetent cells. But the intensities of cell infiltration in the early and late phases after transplantation did not correlate with eventual outcome. Donor-specific NPC decreased to 18-25% on day + 10 in both therapeutic groups, but had rebounded to up to 40% by day + 100. Recurrence of donor-specific cells was caused almost exclusively by rising T cell counts. The persistence of dendritic cells in the late phase after transplantation could be clearly demonstrated. Repopulation by donor-specific T lymphocytes was observed in long-term accepted liver grafts. This recurrence may be based on the differentiation of liver-derived progenitor cells. The persistent coexistence of donor and recipient cells within the liver allograft (intrahepatic chimerism) appears to be characteristic and may be important for long-term acceptance.
同种异体大鼠肝移植后的长期移植物接受和耐受诱导已得到充分描述。然而,其潜在机制仍不清楚。在本研究中,我们调查了初始免疫抑制和长期接受过程中肝移植物内的细胞事件。在Dark Agouti(DA)到Lewis(LEW)和LEW到DA大鼠品系组合中进行了原位肝移植。为了实现长期接受,DA肝的LEW受体接受了两种不同的短期治疗。在移植后第10天和第100天从肝同种异体移植物中分离出非实质细胞(NPC),并通过流式细胞术对供体特异性白细胞进行免疫表型分析。单药治疗和三联治疗均延长了移植物存活时间(>100天)。来自LEW供体的肝同种异体移植物在完全MHC不匹配的情况下可在无免疫抑制的情况下被DA受体自发接受。肝同种异体移植物排斥反应是由浸润的同种异体反应性免疫活性细胞诱导的。但移植后早期和晚期的细胞浸润强度与最终结果无关。在两个治疗组中,供体特异性NPC在第10天降至18 - 25%,但到第100天时已反弹至高达40%。供体特异性细胞的复发几乎完全是由T细胞计数增加引起的。移植后期树突状细胞的持续存在可以清楚地证明。在长期接受的肝移植物中观察到供体特异性T淋巴细胞的重新填充。这种复发可能基于肝源性祖细胞的分化。肝同种异体移植物内供体和受体细胞的持续共存(肝内嵌合)似乎是其特征,并且可能对长期接受很重要。